{
    "2019-05-31": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Notable Friday Option Activity: MSFT, ABBV, LRCX",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "MSFT",
                        "ABBV",
                        "LRCX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "semiconductors"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dividend",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Vertex Selects Triple Combo Regimen for Regulatory Submission",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Triple Combo",
                        "Regulatory Submission"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Comparing AbbVie’s and Amgen’s 2019 Revenue Growth Trajectories",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Amgen",
                        "Revenue Growth",
                        "Trajectories"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}